Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 October 2022 | Story Gerda-Marié van Rooyen
Gali Mokgosi
Gali Mokgosi uses her passion for students and films to promote conversations about mental health and how campus life inside and outside the classroom – including residence life – affects and is affected by the physical, mental, and spiritual health of its students.

Using her experience in theatre and her passion for students, Gali Mokgosi, Residence Head of House Madelief, helps students explore and implement skills to cope with the demands of university life. A Health and Wellness coordinator for residence life, she helps improve their lives by teaching them the value of sufficient sleep, nutrition, exercise, recreation, positive coping strategies, healthy social and sexual relationships, and a sense of belonging within residences.

Mentoring and supporting university students

As a former English lecturer for first-year students, this go-getter saw an urgency to mentor and support university students. In 2016, she landed a job as residence head and resigned from lecturing to focus on theatre and residence affairs. Soon after her appointment, she and her colleague, Nthabiseng Mokhethi, Residence Head of House Ardour, were asked to coordinate the Residence Life Health and Wellness portfolio at a time when there were many suicide attempts and mental health issues, and drug and alcohol abuse plagued residences.

“Our main responsibility as Health and Wellness coordinators is to support Residence Committee Health and Wellness representatives (RCHW) in their respective residences. We facilitate training for RCHW peers and help them to think broadly about how campus life inside and outside the classroom – including residence life – affects and is affected by the physical, mental, and spiritual health of its students.”

Using film to address topical issues

With an honours degree in Drama and Theatre Arts, this UFS alumna knew she had to adapt to virtual means for her portfolio to continue supporting students during COVID-19.

“There was a need for intervention, and I saw an opportunity to close this gap by helping students through their challenges using films. I wrote films that directly address the challenges students were/are facing. Being a residence head, content for my films is always under my nose, and the storyline is undeniably relevant to them.”

Mokgosi wrote and produced four films for the various student support offices, with the help of Shibashiba Moabelo, Institutional HIV/AIDS Programme Coordinator at Kovsie Health, and Pulane Malefane, Assistant Director: Residence Life. These films are, I am, Triggers, Versus me, and Monate jou lekker ding.

This scriptwriter says when students can identify themselves in a story, they tend to gravitate towards a solution as suggested by the story. Students across the University of the Free State’s (UFS) three campuses act in the films. After watching a film, students engage with each other and receive tools to explore the story and reflect on the outcomes as suggested by the film.

Proving her sensitivity for inclusiveness, she had an opportunity to be part of the art skills exchange programme in Deaf theatre at Gallaudet University, Washington, DC. She also presented a research paper in Athens, Greece.

Mokgosi is looking forward to experiment with Deaf films in 2023.

Asked how she looks after her mental health, she reveals: “I take care of my mental health through prayer and meditation. I believe the first place to prosper is through my spiritual life. God is my strength from day to day. He is my all in all. Without Him, I will fall.”

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept